MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Pantothenate kinase-associated neurodegenetration(PKAN)"

  • MDS Virtual Congress 2020

    Deep brain stimulation for generalized dystonia

    K. Szalecki, T. Kmiec, H. Koziara, T. Mandat (Warszawa, Poland)

    Objective: Objective : Author presents a group of patients with generalized dystonia treated with deep brain stimulation (DBS). Background: 32 patients (18 male, 16 female)…
  • MDS Virtual Congress 2020

    Pantothenate kinase associated neurodegeneration: A familial case report of two sisters with severe dystonia

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: To report a familial case of severe dystonia associated with Pantothenate kinase associated neurodegeneration (PKAN). Background: Pantothenate kinase associated neurodegeneration (PKAN) is named previously…
  • MDS Virtual Congress 2020

    Diverse Phenotypic Variations Among Siblings with NBIA: A Case Report and Review of Literature

    N. Merghany, A. Al Hasany (Cairo, Egypt)

    Objective: The purpose of this case report and  literature review  is to increase the awareness of  practicing clinicians regarding  the mosaic clinical pattern this disease…
  • MDS Virtual Congress 2020

    PKAN is associated with significant peripheral metabolic alterations in the Dominican Republic cohort

    C. Bass, F. Middleton, C. Muniz, A. Espinoza, M. Santana Jimenez, S. Baser (Pittsburgh, PA, USA)

    Objective: Applying segmental bioimpedance testing to assess peripheral metabolic alterations in PKAN. Background: PKAN is a rare autosomal recessive disorder with >50 different mutations in…
  • MDS Virtual Congress 2020

    Phenotypic analysis of subjects with homozygous and compound heterozygous PANK2 mutations in a single extended pedigree from the Dominican Republic (DR) PKAN cohort

    F. Middleton, C. Muniz, I. Ojukwu, M. Santana Jimenez, P. Stoeter, R. Ericson, A. Espinoza, C. Bass, P. Roa, S. Baser (Santo Domingo, Dominican Republic)

    Objective: Whole exome sequencing and genotypic screening of homozygous and heterozygous PANK2 mutations in the Dominican Republic. Background: PKAN affects 1 in 1,000,000 people worldwide,…
  • 2019 International Congress

    Spastic ataxia and pseudo eye-of-the-tiger sign in a familiy with a novel compound heterozygous AFG3L2 mutations

    G. Buda, S. Vishnopolska, J. Oliveri, F. Olivieri, G. Biagioli, L. Miquelini, A. Pellene, M. Marti, C. Calandra (Buenos Aires, Argentina)

    Objective: Identify by exome sequencing (ES) the underlying etiology of spastic ataxia and pseudo eye-of-the-tiger sign (EOT) in 4 siblings. Background: The EOT is a…
  • 2019 International Congress

    A Systems Approach Model for Pantothenate Kinase-Associated Neurodegeneration (PKAN)- Assessment and Treatment

    S. Baser, C. Muniz, F. Middleton, R. Ericson, C. Bass (Pittsburgh, PA, USA)

    Objective: Propose a new systems approach model for PKAN, investigate treatment, and establish biologic and genetic markers. Background: PKAN is a recessive, rare, inborn error…
  • 2019 International Congress

    Distinct phenotypic expression in a large PKAN cohort in the Dominican Republic

    S. Baser, C. Muniz, F. Middleton, R. Ericson, M. Santana Jimenez, C. Bass (Pittsburgh, PA, USA)

    Objective: Analysis of a large genetically homogenous PKAN population, assessing demographics, clinical features, and rating scales to characterize observed phenotypic heterogeneity. Background: PKAN is an…
  • 2019 International Congress

    Temporal Emergence of Symptoms and Functional Impairments in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

    F. Greblikas, HA. Jinnah, T. Klopstock, A. Videnovic, C. Burns (San Diego, CA, USA)

    Objective: To describe the temporal emergence of PKAN symptoms and functional impairments across the spectrum of PKAN severity. Background: PKAN, an autosomal recessive, progressive neurodegenerative…
  • 2019 International Congress

    Associations of Genetic, Epigenetic and Phenotypic Measures in the Dominican Republic PKAN Cohort

    F. Middleton, A. Espinoza, D. Larocca, R. Ericson, M. Santana Jimenez, K. Wagner, P. Stoeter, C. Bass, C. Muniz, S. Baser (Pittsburgh, PA, USA)

    Objective: To explore relationships between demographic, clinical and behavioral phenotypes and underlying genetic and epigenetic features, utilizing a large cohort of PKAN patients. Background: PKAN…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley